Foreign companies, “We can’t take you to foreign symposiums this year, doc”

‘We can’t do anything.’ Multinational pharmaceutical companies have stopped supporting academic symposiums in regards to doctors.

This is because of the prosecution’s rebate investigations and the ‘Kim Young-Ran Act.’ Particularly, a number of pharmaceutical companies have completely cut off supporting participation in foreign academic symposiums, the key activity for academic promotion.

On...